Treatment priorities and current prescribing patterns in hypertension: Results of GRASP, an international physician survey

Current Medical Research and Opinion

Volumn 20, Issue 7, 2004, Pages 1151-1160

  Volpe, Massimo ^a   Machado, Elizabeth ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b P/S/L Research   (United States)

Author keywords

Antihypertensive medication; Clinical trials; Hypertension; Prescribing patterns; Primary care

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL PRACTICE; DRUG CHOICE; DRUG USE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE;

ANTIHYPERTENSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; DECISION MAKING; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; INTERNATIONALITY; INTERVIEWS; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY PREVENTION; QUESTIONNAIRES;

EID: 3242655722     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125004231     Document Type: Article

References (27)

1. Ezzati M, Hoorn SV, Rodgers A, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003;362:271-80
2. Wolf-Maier K, Copper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9
3. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7
4. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53
5. Chobainian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2650-72
6. World Health Organization, International Society of Hypertension Writing Group. International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92
7. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35
8. Schillaci G, Verdecchia P, Porcellati C, et al. Continuous relation between left ventricular mass and cardiovascular risk in hypertension. Hypertension 2000;35:580-86
9. Brown DW, Giles WH, Crift JB. Left ventricular hypertrophy as a predictor of coronary heart disease and the effect of hypertension. Am Heart J 2000;140:848-56
10. Verdecchia P, Angeli F, Reboldi G, et al. Improved cardiovascular risk stratification by a simple ECG index in hypertension. Am Heart J 2003;16:646-52
11. Schmieder RE, Messerli FH. Hypertension and the heart. J Hum Hypertens 2000;14:597-604
12. Di Tullio MR, Zwas DR, Sacco RL, et al. Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 2003;34:2380-4
13. Maza A, Pessina AC, Pavei A, et al. Predictors of stroke mortality in elderly people from the general population. The Cardiovascular Study in the Elderly. Eur J Epidemiol 2001;17:1097
14. Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003
15. EuroASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EuroASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-72
16. Andersson OK, Almgren T, Persson B, et al. Survival in treated hypertension: follow up study after two decades. BMJ 1998;317:167-71
17. He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens 2003;17:455-7
18. Dewey HM, Thrift AG, Mihalopoulos C, et al. Informal care for stroke survivors: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2002;33:1028-33
19. Kjeldsen SE, Julius S, Hedner T, Hansson L. Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Pressure 2001;10:190-2
20. Anonymous. The greatest threat to women's health (editorial). Lancet 2003;362:1165
21. Kjeldsen SE, Fossum E, Reims HK, Hoøieggen A. Hypertension treatment and stroke prevention. Blood Pressure 2003;12:264-8
22. The Hope (Heart Outcomes Prevention Evaluation) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53
23. Wing LMH, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-92
24. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97
25. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41
26. Fournier A, Oprisiu R, Andrejak M, et al. Reducing the risk of stroke [letter]. JAMA 2003;289:1927
27. Dahlöf B, Burke TA, Carides GW, et al. Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. J Hum Hypertens 2004, advance online publication. 18 March 2004:doi:10.1038/sj.jhh. 1001710